Aignostics Pathology AI Platform

Aignostics is a spin-off from Charite Berlin with offices in Berlin and New York. It develops AI for tissue analysis in pathology, serving life sciences, clinical and academic users.

The offer includes licensing of pathology foundation models, HETA (H&E Tissue Analysis), pre-analyzed datasets and biomarker solutions for pharma, HETA Clinical products and the PathoSearch visual case search for clinical teams, and open research resources such as OpenTME and a research access program for academics.

• Foundation models: licensing of pathology foundation models.
• HETA: H&E tissue analysis for life sciences and clinical use.
• PathoSearch: visual search engine for pathology cases.
• Pre-analyzed datasets: ready tissue data for research and biomarker work.
• Biomarker and target solutions: analysis support for pharma programs.
• OpenTME and research access: resources for academic groups.

A Vietnamese cancer hospital can build a searchable archive of digitized cases. A CRO can quantify the tumor microenvironment in oncology trial slides. A university can use open datasets for pathology AI research.

Foundation model licensing lets pharma and labs build on pretrained models. Pre-analyzed datasets save data preparation time. ISO 13485 and ISO 27001 certifications support quality and security reviews. A GCP-ready clinical trial platform supports regulated studies.

Pathology foundation models are moving AI from single-task algorithms to general tissue analysis used in drug development and diagnostics. In Vietnam and Southeast Asia, research hospitals and CROs running oncology trials can use such tools as digital slide scanning spreads.

Spin-off from Charite Berlin with offices in Berlin and New York. ISO 13485 and ISO 27001 certified per website. Founding year not stated on fetched pages.